全球癌症治疗市场 – 2029 年行业趋势及预测

请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

全球癌症治疗市场 – 2029 年行业趋势及预测

  • Healthcare
  • Upcoming Report
  • Nov 2022
  • Global
  • 350 页面
  • 桌子數: 220
  • 图号: 60

Global Cancer Care Market

市场规模(十亿美元)

CAGR :  % Diagram

Diagram Forecast Period
2022 –2029
Diagram Market Size (Base Year)
USD 170.00 Billion
Diagram Market Size (Forecast Year)
USD 351.37 Billion
Diagram CAGR
%
Diagram Major Markets Players
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5

全球癌症治疗市场,按治疗类型(化疗、靶向治疗、免疫治疗、激素治疗、其他治疗类型)、癌症类型(血癌、乳腺癌、前列腺癌、胃肠道癌、妇科癌、呼吸道/肺癌、其他癌症类型)、最终用户(医院、专科诊所、癌症和放射治疗中心)、治疗类别(G-CSF、双膦酸盐、止吐药、阿片类药物、NSAID、ESA)划分 - 行业趋势和预测到 2029 年。

癌症护理市场

 癌症治疗市场分析和规模

临床研究、医疗保健、体检、自我护理、疾病诊断和治疗、药物和器械治疗、外科治疗、医院管理、药学、药品质量控制和疾病预防均被纳入癌症治疗的考虑范围。癌症是全球第二大死亡原因,2018 年估计有 960 万人死于癌症,即每六人中就有一人死于癌症。男性更容易患肺癌、前列腺癌、结直肠癌、胃癌和肝癌,而女性更容易患乳腺癌、结直肠癌、肺癌、宫颈癌和甲状腺癌。

Data Bridge Market Research 分析,2021 年癌症治疗市场规模为 1700 亿美元,预计到 2029 年将达到 3513.7 亿美元,2022 年至 2029 年预测期内的复合年增长率为 9.50%。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的见解外,Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、管道分析、定价分析和监管框架。

癌症治疗市场范围和细分  

报告指标

细节

预测期

2022 至 2029 年

基准年

2021

历史岁月

2020(可定制为 2014 - 2019)

定量单位

收入(百万美元)、销量(单位)、定价(美元)

涵盖的领域

治疗类型(化疗、靶向治疗、免疫治疗、激素治疗、其他治疗类型)、癌症类型(血癌、乳腺癌、前列腺癌、胃肠道癌、妇科癌症、呼吸道/肺癌、其他癌症类型)、最终用户(医院、专科诊所、癌症和放射治疗中心)、治疗类别(G-CSF、双膦酸盐、止吐药、阿片类药物、NSAID、ESA)

覆盖国家

北美洲的美国、加拿大和墨西哥、德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 的其他地区、巴西、阿根廷和南美洲其他地区

涵盖的市场参与者

Astellas Pharma US, Inc. (U.S.), Johnson & Johnson Services, Inc (U.S.), Sanofi (France), Ipsen Pharma (France), AbbVie Inc. (U.S.), Myovant Sciences GmbH (U.K.), Bayer AG (Germany), AstraZeneca (U.K.), Tolmar Pharmaceuticals, Inc. (U.S.), Ferring B.V. (Switzerland), Takeda Pharmaceutical Company Limited (Japan), Teva Pharmaceutical Industries Ltd. (Israel), Pfizer Inc (U.S.), Dendreon Pharmaceuticals LLC. (U.S.), Bristol-Myers Squibb Company (U.S.), Abbott (U.S.), GSK plc (U.K.), F. Hoffmann-La Roche Ltd (Switzerland), Genentech, Inc (U.S.) and Novartis AG (Switzerland)

Market Opportunities

  • Rising disposable incomes and constant improvements in healthcare infrastructure
  • Increasing prevalence of cancer

Market Definition

Cancer is a disease in which certain cells in the body grow uncontrollably and spread to other parts of the body. Cancer can develop almost anywhere in the human body, which contains trillions of cells. Human cells normally grow and multiply (a process known as cell division) to form new cells as the body requires them. Cells die when they become old or damaged, replacing new cells.

Global Cancer Care Market Dynamics

Drivers

  • The elderly population is more prone to cancer

Hospital outpatient evaluation and management (E&M) visits fell by 74%, new patient E&M visits fell by 70%, and current patient E&M visits fell by 60%. The overall condition returned to normal around the second quarter of 2021. The rising cancer incidence and population ageing are two of the most important factors driving market growth. Globocan predicts that the number of new cancer cases will rise by 47% from 2020 to 28.4 million over the next two decades. Furthermore, the elderly are more vulnerable to cancer, and life expectancy in developing countries has surpassed 80 years. These are the certain factors which help the market to grow.

  • Increased cancer prevalence and unfavourable effects

The market for cancer care is being driven by a number of factors, including the rising incidence of cancer and the negative side effects associated with cancer drug use, as well as an increase in the global elderly population. Furthermore, an increase in the use of biosimilars and an increase in government healthcare spending contribute to the growth of the market for cancer-supportive care medications.

Opportunities

  • Increase in targeted therapy medication advancements

Patients and medical professionals now prefer these treatments over others because they have fewer side effects than other options. This is due to increased research and development of targeted therapy medications in recent years. As a result, there will be a direct impact on expanding the market for pharmaceuticals used in supportive cancer care.

Restraints/Challenges

  • Side effects associated with targeted therapy medications

患者和医生发现并偏爱副作用较小的靶向治疗药物,直接影响癌症治疗市场的增长,但也可能阻碍该行业的增长。此外,生物仿制药的审批过程冗长,也阻碍了市场的增长。

本癌症护理市场报告详细介绍了最新发展、贸易法规、进出口分析、生产分析、价值链优化、市场份额、国内和本地市场参与者的影响,分析了新兴收入领域的机会、市场法规的变化、战略市场增长分析、市场规模、类别市场增长、应用领域和主导地位、产品批准、产品发布、地域扩展、市场技术创新。如需了解有关癌症护理市场的更多信息,请联系 Data Bridge Market Research 获取分析师简报,我们的团队将帮助您做出明智的市场决策,实现市场增长。

最新动态

  • 2022 年 6 月,Heron Therapeutics 宣布发布 ZYNRELEF,作为围手术期非阿片类多模式镇痛方案的基础,减少了全膝关节置换术患者的剧烈疼痛和阿片类药物的使用。
  • 2022 年 3 月,Heron Therapeutics 从医疗保险和医疗补助服务中心获得了 ZYNRELEF 的转嫁支付状态,允许在医院门诊护理环境中进行单独报销。

全球癌症治疗市场范围

癌症护理市场根据治疗类型、癌症类型、最终用户和治疗类别进行细分。这些细分市场之间的增长情况将帮助您分析行业中增长缓慢的细分市场,并为用户提供有价值的市场概览和市场洞察,帮助他们做出战略决策,确定核心市场应用。

治疗类型

  • 化疗
  • 靶向治疗
  • 免疫疗法
  • 激素治疗
  • 其他治疗类型

 癌症类型

  • 血癌
  • 乳腺癌
  • 前列腺癌
  • 胃肠道癌症
  • 妇科癌症
  • 呼吸道/肺癌
  • 其他癌症类型

最终用户

  • 医院
  • 专科诊所
  • 癌症和放射治疗中心

 治疗课程

  • 集落刺激因子
  • 双膦酸盐
  • 止吐
  • 阿片类药物
  • 非甾体抗炎药
  • 职业安全健康署

癌症治疗市场区域分析/见解

对癌症治疗市场进行了分析,并按上述国家、治疗类型、癌症类型、最终用户和治疗类别提供了市场规模见解和趋势。

癌症治疗市场报告涵盖的国家包括北美洲的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、亚太地区 (APAC) 的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 的其他地区、南美洲的巴西、阿根廷和南美洲其他地区。

由于全球老年人口的增加和政府在 医疗保健方面的支出,北美在癌症治疗市场占据主导地位。

由于癌症患者人数增加,预计亚太地区将在 2022 年至 2029 年的预测期内以最高增长率增长。由于中东、非洲和拉丁美洲的癌症治疗意识不断提高,预计这些国家的癌症治疗市场将出现增长。

报告的国家部分还提供了影响单个市场因素和国内市场监管变化,这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外,在提供国家数据的预测分析时,还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。

竞争格局和癌症治疗市场份额分析

癌症护理市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对癌症护理市场的关注有关。

癌症治疗市场的一些主要参与者包括:

  • 安斯泰来制药美国公司(美国)
  • 强生服务公司(美国)
  • 赛诺菲(法国)
  • 益普生制药(法国)
  • AbbVie Inc.(美国)
  • Myovant Sciences GmbH(英国)
  • 拜耳公司(德国)
  • 阿斯利康(英国)
  • Tolmar Pharmaceuticals, Inc.(美国)
  • Ferring BV(瑞士)
  • 武田药品工业株式会社 (日本)
  • Teva Pharmaceutical Industries Ltd.(以色列)
  • 辉瑞公司 (美国)
  • Dendreon Pharmaceuticals LLC.(美国)
  • 百时美施贵宝公司 (美国)
  • 雅培(美国)
  • 葛兰素史克公司 (英国)
  • F. Hoffmann-La Roche Ltd(瑞士)
  • 基因泰克公司(美国)
  • 诺华公司(瑞士)


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The cancer care market value was USD 170 billion in 2021.
The cancer care market is projected to grow at a CAGR of 9.50% during the forecast period of 2022-2029.
Cancer Care Market report is segmented by Treatment Type, Cancer Type, End User, Therapeutic Class
North America dominates the cancer care market due to the rise in global geriatric population and government expenditures on healthcare.